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Research
Twenty years after the 1990–1991 Gulf War, 
military personnel who served in that con‑
flict continue to report health problems that 
are not adequately explained by established 
medical or psychiatric diagnoses [Institute of 
Medicine 2010; Kang et al. 2009; Ozakinci 
et al. 2006; Research Advisory Committee on 
Gulf War Veterans’ Illnesses (RAC‑GWVI) 
2008]. Studies of diverse Gulf War veteran 
popu  la  tions consistently describe a sympto‑
matic illness that affects Gulf War veterans 
at significantly elevated rates compared with 
other military populations (Fukuda et al. 
1998; Goss Gilroy Inc. 1998; Kang et al. 
2000; Steele 2000; Unwin et al. 1999). 
Symptom profiles typically include some 
combination of chronic headache, widespread 
pain, memory and concentration problems, 
persistent fatigue, gastro  intestinal problems, 
skin abnormalities, and mood disturbances. 
Considered together, these undiagnosed 
symptoms are commonly referred to as Gulf 
War illness (GWI).
Studies suggest that at least 25% of the 
nearly 700,000 U.S. veterans of the 1990–1991 
Gulf War are affected by GWI (Kang et al. 
2009; RAC‑GWVI 2008). Understanding the 
cause or causes of GWI has posed a complex 
research challenge in the years since the Gulf 
War. The 1990–1991 Gulf War itself was 
remarkably short, ending after just 6 weeks 
of air strikes and 4 days of ground combat. 
Like personnel in other hostile deployments, 
some Gulf War troops experienced trauma 
and extreme psycho  logi  cal stress in theater. 
Studies indicate, however, that such experi‑
ences and their psychiatric sequelae were much 
less common in the brief 1990–1991 Gulf 
War than in other conflicts (Ismail et al. 2002; 
RAC‑GWVI 2008).
Concerns have been raised about the many 
potentially hazardous substances encoun‑
tered by Gulf War personnel in theater. These 
include the oily black smoke generated by 
> 600 burning oil well fires that darkened 
Kuwaiti skies for much of 1991, low‑level 
exposure to chemical nerve agents, pyrido‑
stigmine bromide (PB) pills taken by U.S. and 
some coalition forces to protect against acute 
effects of nerve agents, excessive use of pesti‑
cides and insect repellants, munitions contain‑
ing depleted uranium, receipt of numerous 
vaccines, and diverse other potential hazards.
Determining the specific causes of GWI 
has been hindered by a lack of measured data 
indicating who was exposed to what during 
the war, and at what levels. Epidemiologic 
studies have therefore evaluated risk factors 
for GWI based on veterans’ own reports of 
their exposures during deployment. Some 
studies have suggested that nearly all of the 
many experiences and exposures queried 
appear to be linked to poor health outcomes 
(Barrett et al. 2002; Hotopf and Wessely 
2005). Others have identified only a limited 
number of significant risk factors for GWI 
(Haley and Kurt 1997; Nisenbaum et al. 
2000; Wolfe et al. 2002). Reports also indi‑
cate that the many exposures associated with 
Gulf War service are highly inter  correlated 
(Cherry et al. 2001; Fricker et al. 2000), sug‑
gesting the potential for confounding errors 
in evaluating associations between GWI and 
Gulf War exposures.
In 2008, the RAC‑GWVI, a congres‑
sionally mandated federal advisory panel, 
released a comprehensive review of scientific 
literature and government‑issued reports per‑
taining to the health of Gulf War veterans 
(RAC‑GWVI 2008). The report described 
limitations in existing Gulf War epidemio‑
logic studies, specifically pointing out that 
studies have often failed to assess risk factors 
for GWI using analytic methods appropriate 
for the complex Gulf War exposure scenario. 
The panel recom  mended that studies of Gulf 
War veterans evaluate GWI risk factors in 
veteran subgroups that may be relevant to the 
outcomes of interest and use analytic methods 
that consider possible confounding effects of 
concurrent exposures.
We report here results of a case–control 
study initiated in 2000 as part of a multi‑
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Ba c k g r o u n d: At least one-fourth of U.S. veterans who served in the 1990–1991 Gulf War are 
affected by the chronic symptomatic illness known as Gulf War illness (GWI). Clear determination 
of the causes of GWI has been hindered by many factors, including limitations in how epidemio-
logic studies have assessed the impact of the complex deployment environment on veterans’ health.
oB j e c t i v e: We sought to address GWI etiologic questions by evaluating the association of symp-
tomatic illness with characteristics of veterans’ deployment.
Me t h o d s : We compared veteran-reported wartime experiences in a population-based sample 
of 304 Gulf War veterans: 144 cases who met pre  established criteria for GWI and 160 controls. 
Veteran subgroups and confounding among deployment variables were considered in the analyses.
re s u l t s: Deployment experiences and the prevalence of GWI differed significantly by veterans’ 
location in theater. Among personnel who were in Iraq or Kuwait, where all battles took place, 
GWI was most strongly associated with using pyridostigmine bromide pills [odds ratio (OR) = 3.5; 
95% confidence interval (CI): 1.7, 7.4] and being within 1 mile of an exploding SCUD missile 
(OR = 3.1; 95% CI: 1.5, 6.1). For veterans who remained in support areas, GWI was significantly 
associated only with personal pesticide use, with increased prevalence (OR = 12.7; 95% CI: 2.6, 
61.5) in the relatively small subgroup that wore pesticide-treated uniforms, nearly all of whom also 
used skin pesticides. Combat service was not significantly associated with GWI.
co n c l u s i o n s: Findings support a role for a limited number of wartime exposures in the etiology of 
GWI, which differed in importance with the deployment milieu in which veterans served.
key wo r d s: confounding, etiology, Gulf War illness, pesticides, pyridostigmine bromide. 
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part project to evaluate possible associations 
between GWI and a) veterans’ experiences and 
exposures in theater, b) variability in enzymes 
that metabolize a number of exposures linked 
with Gulf War service, and c) function of the 
autonomic nervous system. Results of labo‑
ratory and physiologic assessments will be 
provided elsewhere. Here we focus on evalua‑
tion of associations between GWI and charac‑
teristics of veterans’ military service during the 
Gulf War. In particular, we attempt to clarify 
some of the ambiguities and apparent incon‑
sistencies from previous studies by identifying 
veteran subgroups of importance and control‑
ling for spurious effects that can result from 
confounding errors introduced by multiple 
concurrent exposures.
Methods
Study population and recruitment. This study 
had a case–control design involving a popula‑
tion‑based sample of 304 veterans who served 
in the 1990–1991 Gulf War. In 2000, a ran‑
dom sample of Gulf War veterans, stratified 
by sex, was identified from among veterans 
residing in the greater Kansas City metropoli‑
tan area, including both Kansas and Missouri 
residents. The sampling pool for Kansas 
residents was drawn from a database of all 
Kansas Gulf War–era veterans maintained by 
the Kansas Commission on Veterans Affairs 
(Topeka, KS). Gulf War veteran residents of 
Missouri were sampled from among area vet‑
erans identified through the U.S. Department 
of Defense’s (DOD) Defense Manpower Data 
Center (Seaside, CA). 
Potential study participants were contacted 
by telephone and invited to complete a brief 
screening interview to determine study eligi‑
bility. Eligible veterans were required to have 
deployed to the Gulf War theater of operations 
for any period between 1 August 1990 and 
31 July 1991. To optimize the proportions of 
cases and controls enrolled, the screening inter‑
view queried veterans about 10 symptoms to 
determine if they screened positive or negative 
for multi  symptom illness (sMSI+ or sMSI–), 
as defined by Fukuda et al. (1998). Briefly, 
sMSI+ veterans reported at least one symp‑
tom in two of the following symptom groups: 
a) fatigue, b) mood/cognition, and c) musculo‑
skeletal pain. sMSI– veterans reported fewer or 
no symptoms.
In accordance with the GWI case defini‑
tion used for the study, potential participants 
were excluded if they reported being diag‑
nosed by a physician with chronic medical 
conditions that might account for their symp‑
toms (including diabetes, heart disease other 
than hyper  tension, stroke, lupus, multiple 
sclerosis, cancer other than non  melanoma 
skin cancers, liver disease) or had persistent 
health problems due to chronic infection or 
serious injury. Veterans were also excluded if 
they reported being diagnosed with schizo‑
phrenia or bipolar disorder or if they had 
been hospitalized since the Gulf War for alco‑
hol or drug dependence, depression, or post‑
traumatic stress dis  order (PTSD).
Veterans determined to be eligible were 
invited to come to the study site to provide 
blood samples for genetic/enzyme activity 
testing and to complete a self‑administered 
questionnaire providing information on their 
health, military, and deployment charac  teris‑
tics. Recruitment continued until a final sample 
of at least 300 veterans completed appoint‑
ments at the study site, including simi  lar num‑
bers of sMSI+ and sMSI– veterans, with similar 
proportions of women in each group.
Among the 906 households initially con‑
tacted, informants indicated that 76 veter‑
ans could not participate (71 were deployed 
or no longer in the area, 5 were deceased); 
86 (9%) refused to provide information or be 
interviewed. Of the remaining 744 veterans, 
98 (13%) reported they had not deployed to 
the Persian Gulf region during the required 
period, and 646 completed the screening inter‑
view. Overall, 288 (45%) of the 646 veter‑
ans screened sMSI+ and 358 (55%) screened 
sMSI–. A total of 121 veterans were ineligi‑
ble for the study based on health exclusions, 
450 were eligible and were invited to partici‑
pate, and 75 qualified but were not recruited 
based on their sMSI status or sex. Of the 
450 recruited veterans, 385 (86%) agreed to 
participate, and 304 (68%) completed appoint‑
ments at the study site.
Among the 121 veterans excluded for 
health reasons, 102 were excluded for one or 
more medical conditions, 12 were excluded 
based on self‑reported psychiatric hospitaliza‑
tions or diagnoses, and 7 were excluded for 
both medical and psychiatric reasons. Leading 
reasons for medical exclusions included 
chronic problems resulting from serious 
injury (n = 27), chronic infection (n = 25), 
heart disease (n = 21), cancer (n = 18), dia‑
betes (n = 18), and liver disease (n = 12). 
Of the 74 veterans who reported physician‑
diagnosed psychiatric conditions, 19 were 
excluded for one or more of the following: 
diagnosed schizophrenia (n = 3) or bipolar 
disorder (n = 8), post  war hospitalization for 
PTSD (n = 2), drug or alcohol dependence 
(n = 8), or depression (n = 6). The remaining 
56 veterans who reported being diagnosed, 
but not hospitalized, for psychiatric condi‑
tions were eligible for the study and remained 
in the sampling pool.
In conducting this research, investigators 
complied with all applicable U.S. regulations 
regarding the protection of human subjects. 
The study was approved by the U.S. Army 
Human Subjects Research Review Board 
and by the institutional review boards of 
Midwest Research Institute and the Kansas 
Department of Health and Environment. 
Veteran participants gave both oral and writ‑
ten informed consent before enrolling in the 
study. Data were collected from September 
through December 2000.
Questionnaire. In the absence of a standard 
instrument used in studies of Gulf War vet‑
erans, we developed a questionnaire based on 
health and exposure questions representative of 
those used in several large population‑based sur‑
veys of Gulf War veterans (Fukuda et al. 1998; 
Iowa Persian Gulf Study Group 1997; Kang 
et al. 2000; Steele 2000). The questionnaire 
asked veterans to report information related to 
their military and demographic charac  teristics, 
their health and medical histories, and the time 
periods and locations in which they served dur‑
ing the war. Deployment locations were identi‑
fied using a map of the Gulf War theater of 
operations on which geographic regions were 
identified. Veterans were asked if they had been 
in each of the areas during deployment and, if 
so, for how long. Veterans were also asked if 
they had 19 specific experiences or exposures 
of interest during deployment. These ques‑
tions emphasized veterans’ experiences rather 
than their impressions of their exposures. For 
example, veterans were not asked simply if they 
had been exposed to depleted uranium (which 
many were unlikely to have known) but if they 
had contact with destroyed enemy vehicles, 
an experience required for nearly all personnel 
directly exposed to spent depleted uranium. 
Symptom questions included those used to 
assess case status based on the Kansas GWI 
case definition, described below, as well as MSI 
defined by Fukuda et al. (1998), commonly 
referred to as the Centers for Disease Control 
and Prevention (CDC) case definition. The 
questionnaire was pretested in a group of 
Kansas Gulf War veterans who lived outside 
the sampling area.
Case definition. GWI case status was 
determined using a previously described case 
definition developed in a large epidemiologic 
study of Kansas Gulf War era veterans (Steele 
2000). This case definition is based on an 
empirically identified pattern of symptoms 
found to significantly distinguish Gulf War 
veterans from veterans who had served during 
the same time period but did not deploy to 
the Persian Gulf theater. Briefly, the defini‑
tion requires GWI cases to have multiple and/
or moderate‑to‑severe chronic symptoms in at 
least three of six defined symptom domains. 
Qualifying symptoms must have first been a 
problem during or after the Gulf War and per‑
sisted over the 6‑month period preceding the 
study. Symptom domains include a) fatigue/
sleep problems, b) somatic pain, c) neuro‑
logic/cognitive/mood symptoms, d) gastro‑
intestinal symptoms, e) respiratory symptoms, 
and f ) skin abnormalities. Kansas GWI case 
criteria also exclude veterans who report being Steele et al.
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diagnosed with medical or psychiatric condi‑
tions that could explain their symptoms or 
interfere with their ability to report them, as 
detailed above in the exclusionary criteria for 
this study. Controls had insufficient symptoms 
to meet GWI case criteria and also reported no 
exclusionary diagnoses.
The Fukuda/CDC MSI criteria, described 
above (Fukuda et al. 1998), provided the basis 
for our initial screening of veterans for the 
study sample. Overall, these criteria are less 
restrictive (i.e., they identify a broader range 
of cases) than the Kansas GWI criteria. This 
is because of the lesser number and severity of 
chronic symptoms required for CDC cases and 
because the CDC definition does not exclude 
veterans with medical or psychiatric diagnoses 
that potentially account for their symptoms. 
Data analyses. We compared demographic 
and general health charac  teristics of GWI 
cases and controls using chi‑square statistics. 
Bivariate (unadjusted) associations between 
case status and deployment and military 
charac  teristics were determined by calculating 
crude prevalence odds ratios (ORs) and 95% 
confidence intervals (CIs).
Preliminary analyses indicated that GWI 
case status was strongly associated with veter‑
ans’ reports of having been in Iraq, Kuwait, 
or both during deployment, regardless of 
the duration of time spent in those areas. To 
further evaluate associations between location 
in theater and deployment characteristics, four 
mutually exclusive veteran subgroups were 
defined: a) veterans who reported ever being 
in Iraq or Kuwait; or veterans who had not 
been in Iraq or Kuwait who were b) primarily 
at sea while in theater, c) primarily in eastern 
Saudi Arabia, or d) primarily on land in other 
support areas. The distribution of deployment 
experiences and exposures reported by veterans 
in each location subgroup was assessed using 
chi‑square analyses.
Because the number of veterans in some 
location subgroups did not accommodate 
multi  variable modeling of exposures in rela‑
tion to case status, veterans who had not 
entered Iraq or Kuwait were combined into a 
single subgroup. We used a two‑step process 
to identify independent associations between 
exposures and GWI for all veterans combined 
and for the two location subgroups of inter‑
est. First, ORs and 95% CIs were calculated 
to determine bivariate associations between 
case status and each exposure. All exposure 
variables that were significantly associated (at 
p < 0.05) with GWI in bivariate analyses were 
entered into a single logistic regression model 
to identify independent associations between 
these variables and GWI. Variables that had 
the weakest association with GWI (i.e., those 
with the smallest ORs) were dropped from 
the model sequentially until only those signifi‑
cantly associated with GWI remained. In the 
second step of the process, logistic regression 
analyses were used to determine multi  variable 
associations for each individual exposure que‑
ried, controlling only for effects of the vari‑
ables that were significantly associated with 
GWI in the backward elimination process.
Because very few veterans in the sample 
reported being directly involved in air combat 
or using flea collars during deployment, those 
two variables were not included in the model‑
ing analyses. In addition, all “don’t know,” 
“refuse,” and unclear responses were coded 
as missing values for purposes of analysis. 
For most variables, this included only a small 
number of responses (≤ 3). However, the 
number was considerably higher for several 
variables: exposure to chemical agent resistant 
coating (CARC) paint (27 missing values), 
receipt of shots (injections) in the buttocks 
(19 missing) or arm (17 missing), and prox‑
imity to an exploded SCUD missile (12 miss‑
ing). All analyses were conducted using SAS 
statistical software (version 9.2; SAS Institute 
Inc., Cary, NC).
Results
Study population. The final study popula‑
tion consisted of 304 Gulf War veterans: 
144 GWI cases and 160 controls. By design, 
a simi  lar proportion of women veterans were 
in each group. Cases were also similar to con‑
trols in terms of age, but significantly lower 
proportions of cases were white and had 
earned college degrees (Table 1). Twenty‑
three veterans in the sample reported a history 
of ≥ 1 physician‑diagnosed psychiatric condi‑
tions, including 16 with depression (10 cases, 
6 controls; p = 0.46), 4 with alcohol or drug 
dependence (1 case, 3 controls; p = 0.37), and 
5 with PTSD (3 cases, 2 controls; p = 0.84). 
Cases and controls reported similar general 
health status before Gulf War deployment, 
but cases reported significantly worse general 
health at the time of the study.
Bivariate (unadjusted) associations 
between GWI and deployment characteris­
tics. As detailed in Table 2, cases and controls 
differed markedly with respect to their mili‑
tary charac  teristics at the time of deployment 
and the specific experiences they reported 
in theater. GWI was significantly associ‑
ated with being in the Army compared with 
other branches of service, with serving in the 
enlisted ranks, and with veterans’ deployment 
locations. The prevalence of GWI was almost 
six times higher in veterans who were in Iraq 
and/or Kuwait, where all battles took place, 
than in veterans located primarily at sea. In 
addition, 14 of the 19 wartime experiences 
and exposures about which veterans were 
asked were reported by a significantly greater 
proportion of cases than controls.
Table 1. Demographic and health characteristics of GWI cases and Gulf War veteran controls [n (%)].a
Characteristic  GWI cases (n = 144) Controls (n = 160) p-Value
Sex 0.80
Male 133 (92) 149 (93)
Female 11 (8) 11 (7)
Age at time of study (years) 0.30
29–39 83 (58) 106 (66)
40–49 41 (28) 36 (22)
≥ 50 20 (14) 18 (11)
Race 0.01
White 117 (83) 148 (94)
Black 19 (13) 7 (4)
Other 5 (4) 3 (2)
Hispanic ethnicity 9 (6) 6 (4) 0.31
Education level 0.01
< 4-year college degree 96 (68) 85 (53)
≥ 4-year college degree  46 (32) 75 (47)
Veteran-reported history of psychiatric diagnosesb 13 (9) 10 (6) 0.36
Health status just before deployment 0.55
Excellent 106 (75) 112 (71)
Good 34 (24) 45 (28)
Fair 2 (1) 1 (1)
Health status at time of study < 0.001
Excellent 3 (2) 39 (25)
Good 56 (39) 111 (70)
Fair 66 (46) 8 (5)
Poor 17 (12) 0 (0)
Regular smoker during deployment 0.11
Yes 54 (38) 47 (29)
No 88 (62) 113 (71)
Regular smoker at time of study 0.13
Yes 38 (27) 31 (19)
No 104 (73) 129 (81)
aTotals are not equal in all strata because of missing values for some variables. bReported physician-diagnosed PTSD, 
depression, and/or drug/alcohol dependence; veterans hospitalized for these conditions were not included in the study.Gulf War illness etiology I: wartime exposures
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A large proportion of Army veterans (76% 
overall; 78% of cases, 73% of controls) indi‑
cated they had been in Iraq and/or Kuwait 
during deployment. Stratified analyses to assess 
possible overlap between branch of service and 
deployment location in relation to GWI identi‑
fied a significant interaction between these two 
variables (p < 0.05, Breslow‑Day test for homo‑
geneity of ORs). Specifically, the increased 
prevalence of GWI among Army veterans was 
limited to personnel who remained in sup‑
port areas (OR = 2.78; 95% CI: 1.27, 6.08). 
Army troops who were in Iraq or Kuwait did 
not have a greater prevalence of GWI than did 
personnel from other branches in those areas 
(OR = 1.00; 95% CI: 0.51, 1.94).
Exposure correlations and associations 
with deployment subgroups. Evaluation of 
inter  relationships among veteran‑reported 
deployment experiences, using Pearson’s 
correlation coefficients, indicated a complex 
exposure scenario involving a high degree 
of correlation among deployment‑related 
experiences and exposures (data not shown). 
To further examine the implications of 
these inter  relationships, we determined the 
extent to which exposures were differentially 
reported by veterans who had been located 
in different geographic areas. As shown in 
Table 3, many of the exposures queried were 
reported by a significantly greater proportion 
of veterans who had been in Iraq or Kuwait 
during deployment, compared with veterans 
in other locations.
Multivariable (adjusted) associations 
between GWI and deployment characteris­
tics. Multivariable analyses assessed the inde‑
pendent association of each deployment 
experience/exposure with GWI for all vet‑
erans combined, and for subgroups defined 
by veterans’ locations (Table 4). Controlling 
for effects of specific exposures eliminated 
the significant association between GWI and 
serving in the Army. In contrast with results 
from unadjusted analyses (Table 2), only 
four deployment experiences were signifi‑
cantly associated with GWI in multi  variable 
modeling when all veterans were considered 
together: wearing uniforms treated with pesti‑
cides, taking PB pills, frequently having < 4 hr 
sleep in a 24‑hr period, and being within 
1 mile of an exploding SCUD missile.
Similar multivariable analyses evaluated 
GWI risk in veteran subgroups defined by 
whether they had been in Iraq or Kuwait dur‑
ing deployment. In the subgroup of veterans 
who had entered Iraq and/or Kuwait, four 
exposures were independently associated with 
GWI case status: taking PB pills, being within 
1 mile of an exploding SCUD missile, using 
pesticides on the skin, and exposure to smoke 
from oil well fires.
Among veterans who did not enter Iraq or 
Kuwait, those who reported wearing uniforms 
Table 2. Military and deployment characteristics for GWI cases and controls [n (%)].a
Characteristic 
GWI cases 
(n = 144)
Controls 
(n = 160)
Unadjusted OR 
(95% CI)
Military characteristicb
Branch of service
Navy 15 (10) 34 (21) 1.0 (referent)
Air Force 11 (8) 17 (11) 1.47 (0.55, 3.88)
Marines 25 (17) 33 (21) 1.31 (0.88, 1.95)
Army 93 (65) 75 (47) 2.81 (1.42, 5.54)*
Rank
Officer 20 (14) 43 (27) 1.0 (referent)
Enlisted 124 (86) 117 (73) 2.28 (1.27, 4.10)*
Deployment locationb 
Did not enter Iraq or Kuwait
Primarily at sea during deployment 6 (4) 26 (16) 1.0 (referent)
On land in support locations 37 (26) 58 (36) 2.76 (1.04, 7.36)*
Entered Iraq and/or Kuwait 101 (70) 76 (48) 5.76 (2.26, 14.7)*
Experience or exposurec
Wore a flea collar 7 (5) 1 (1) 8.13 (1.02, 368)*
Wore uniforms treated with pesticides 38 (27) 14 (9) 3.72 (1.91, 7.21)*
Took PB pills 98 (72) 68 (44) 3.21 (1.97, 5.24)*
Used pesticides on skin 80 (57) 49 (31) 2.89 (1.80, 4.64)*
Saw Iraqis/civilians badly wounded or killed 93 (65) 64 (40) 2.71 (1.70, 4.31)*
Contact with destroyed enemy vehicles 86 (60) 57 (36) 2.63 (1.65, 4.18)*
Contact with prisoners of war 84 (59) 56 (35) 2.62 (1.64, 4.17)*
Exposed to smoke from oil well fires 117 (82) 103 (65) 2.40 (1.41, 4.11)*
Frequently had < 4 hr sleep in 24 hr 96 (69) 79 (49) 2.24 (1.39, 3.59)*
Saw or came in contact with dead animals 75 (54) 54 (34) 2.20 (1.38, 3.51)*
SCUD missile exploded within 1 mile 67 (48) 47 (31) 2.10 (1.30, 3.39)*
Used or had contact with fresh CARC paint 38 (29) 24 (17) 2.04 (1.14, 3.63)*
Received ≥ 1 shot in the arm in theater 99 (73) 88 (58) 2.00 (1.21, 3.29)*
Received ≥ 1 shot in buttocks in theater 57 (43) 45 (29) 1.82 (1.12, 2.98)*
Directly involved in ground combat 45 (32) 40 (25) 1.42 (0.86, 2.36)
Saw living area sprayed/fogged with pesticides 30 (22) 29 (17) 1.33 (0.74, 2.37)
Saw U.S. or allied troops badly wounded or killed 56 (39) 52 (33) 1.31 (0.82, 2.11)
Heard chemical alarms sounded 84 (59) 82 (53) 1.31 (0.83, 2.07)
Directly involved in air combat 9 (6) 8 (5) 1.27 (0.48, 3.38)
aTotals are not equal in all strata because of missing values for some variables. bORs are GWI prevalence ORs for each 
characteristic, compared with the referent group. cORs are GWI prevalence ORs for having each experience/exposure, 
compared with not having the experience/exposure. *p < 0.05. 
Table 3. Variation in veteran-reported Gulf War experiences and exposures by location in theater.
Not in Iraq or Kuwait
Experience or exposure
At sea 
(n = 32)
Eastern Saudi Arabia 
(n = 56)
On land, other 
(n = 39)
In Iraq or Kuwait 
(n = 177)
Wore a flea collar — — — —
Wore uniforms treated with pesticides ↓ — ↓ ↑
Took PB pills ↓↓ — ↓↓ ↑↑
Used pesticides on skin ↓ — — ↑↑
Saw Iraqis/civilians killed/wounded ↓↓ ↓↓ ↓↓ ↑↑
Contact with destroyed enemy vehicles ↓↓ ↓↓ ↓↓ ↑↑
Contact with prisoners of war ↓↓ ↓ ↓↓ ↑↑
Exposed to smoke from oil well fires ↓↓ — ↓↓ ↑↑
Frequently had < 4 hr sleep in 24 hr ↓ ↓ ↓ ↑↑
Saw or came in contact with dead animals ↓↓ ↓ ↓↓ ↑↑
SCUD missile exploded within 1 mile ↓↓ ↑ — —
Used/exposed to fresh CARC paint ↓ ↓↓ ↓ ↑↑
Received shot(s) in arm while in theater ↓ — — —
Received shot(s) in buttocks while in theater ↓ — — ↑
Directly involved in ground combat ↓↓ ↓↓ ↓↓ ↑↑
Saw living area sprayed with pesticides ↓ — — —
Saw U.S./allied troops killed/wounded ↓ — — ↑↑
Heard chemical alarms ↓ ↑ ↓↓ —
Directly involved in air combat — ↓ — —
Data are experiences or exposures reported as having a significantly lower (↓, p < 0.05; ↓↓, p < 0.001) or higher 
(↑, p < 0.05; ↑↑, p < 0.001) proportion in the subgroup compared with all others. —, No significant difference between 
subgroup and all others. Steele et al.
116  v o l u m e  120 | n u m b e r 1 | January 2012  •  Environmental Health Perspectives
treated with pesticides had a substantially 
increased risk for GWI (OR = 12.74; 95% 
CI: 2.64, 61.5; p = 0.002)—the only signifi‑
cant risk factor identified in this subgroup. 
This association was not straightforward, how‑
ever. All but one veteran who reported wear‑
ing pesticide‑treated uniforms also reported 
using pesticides on their skin, so it was not 
possible to estimate the independent effect 
of wearing pesticide‑treated uniforms among 
veterans in this subgroup. In addition, the 
association was based on a limited number 
of observations: 10 exposed cases (24% of 
43 total cases) and 2 exposed controls (2% of 
84 total controls).
Discussion
The difficult‑to‑diagnose symptomatic ill‑
ness that persists among veterans of the brief 
1990–1991 Persian Gulf War has long posed 
a complex scientific challenge. Although epi‑
demiologic investigations have provided con‑
sistent descriptions of GWI, relatively few 
have provided clear insights into its etiology 
or distribution in Gulf War veterans. The 
present study provides strong support for pre‑
vious indications that GWI rates differ with 
veterans’ locations in theater (Goss Gilroy 
Inc. 1998; Iowa Persian Gulf Study Group 
1997; Steele 2000), indicating that veterans 
who were in Iraq and/or Kuwait, where all 
battles took place, had a significantly greater 
prevalence of GWI than did veterans in other 
locations. Our findings also provide a plau‑
sible explanation for these differences, indi‑
cating that many deployment exposures of 
concern were most prominent among troops 
that had been in Iraq and/or Kuwait.
In evaluating individual risk factors, we 
found that results of simple bivariate analyses 
gave an initial impression that nearly all Gulf 
War exposures were significantly associated 
with GWI. However, stratified analyses to 
accommodate differences among veteran sub‑
groups and logistic modeling to control for 
confounding provided a more credible risk 
factor picture. Final results indicate that only 
a limited number of exposures were signifi‑
cantly associated with GWI and that associa‑
tions with specific exposures varied with the 
deployment milieu in which veterans served.
For forward‑deployed personnel, GWI 
was most strongly associated with use of PB 
pills and proximity to exploded SCUD mis‑
siles. For personnel who remained in sup‑
port areas (i.e., those who were not in Iraq or 
Kuwait), GWI was significantly elevated only 
in the relatively small subgroup of veterans 
who wore pesticide‑treated uniforms, most of 
whom also had used skin pesticides.
Most veteran‑reported deployment expe‑
riences and exposures were not significantly 
associated with GWI, when analyses took into 
account effects of other exposures. Experiences 
associated with a high degree of psychological 
stress (e.g., participation in combat, seeing 
others badly wounded or killed) were not sig‑
nificantly associated with GWI in our study. 
Widespread military use of the anthrax vaccine 
first occurred during the Gulf War, with most 
anthrax shots given in theater (DOD 2000). 
However, in our study, veterans who reported 
receiving shots in theater did not have a sig‑
nificantly increased prevalence of GWI when 
other exposures were taken into account. In 
addition, our results do not support a role for 
pesticides used in area fogging, contact with 
dead animals, or exposure to depleted ura‑
nium through contact with destroyed enemy 
vehicles as risk factors for GWI.
Our findings are consistent with those of 
previous studies of Gulf War veterans that 
assessed individual risk factors for symptom‑
atic illness using statistical methods that con‑
trolled for confounding effects of concurrent 
exposures (Cherry et al. 2001; Nisenbaum 
et al. 2000; RAC‑GWVI 2008; Wolfe et al. 
2002). Those studies invariably found, as we 
did here, that relatively few exposures or war‑
time experiences were significantly associated 
with GWI. Overall, the only consistently iden‑
tified risk factors for GWI have been chemical 
exposures—use of PB pills and pesticides—
that can affect the nervous system (Cherry 
et al. 2001; Haley and Kurt 1997; Nisenbaum 
et al. 2000). Studies also consistently find 
that combat stressors are not significant risk 
factors for GWI, when concurrent effects of 
exposures are taken into account (Cherry et al 
2001; Nisenbaum et al. 2000; Wolfe et al. 
2002). Taken together, such results strongly 
suggest that the persistent symptoms affecting 
1990–1991 Gulf War veterans are residual, 
albeit inadequately understood, effects of toxi‑
cants encountered during deployment.
It is important to emphasize that identi‑
fied differences among risk factors for veterans 
in different areas of theater most likely relate 
Table 4. Multivariable association of deployment characteristics [n (%)] with GWI, by location in theater.
All veterans  
(144 GWI cases, 160 controls)
Veterans in Iraq and/or Kuwait 
(101 GWI cases, 76 controls)
Veterans not in Iraq or Kuwait  
(43 GWI cases, 84 controls)
Deployment characteristic
GWI 
cases  Controls
Adjusted ORa 
(95% CI)
GWI 
cases  Controls
Adjusted ORb 
(95% CI)
GWI 
cases Controls
Adjusted ORc 
(95% CI)
Branch of service
Served in the Army (vs. other branches) 93 (65) 75 (47) 1.21 (0.68, 2.14) 73 (72) 55 (72) 0.72 (0.33, 1.59) 20 (47) 20 (24) 1.42 (0.56, 3.60)
Veteran-reported experiences and exposures
Wore uniforms treated with pesticides 38 (27) 14 (9) 2.91 (1.41, 6.01)* 28 (28) 12 (16) 1.35 (0.55, 3.35) 10 (24) 2 (2) 12.74 (2.64, 61.5)*
Took PB pills 98 (72) 68 (44) 2.88 (1.68, 4.94)* 79 (81) 44 (58) 3.50 (1.65, 7.41)* 19 (47) 24 (30) 1.44 (0.59, 3.47)
Frequently had < 4 hr sleep in 24 hr period 96 (69) 79 (49) 2.19 (1.29, 3.73)* 78 (78) 50 (66) 1.99 (0.93, 4.25) 18 (45) 29 (35) 1.56 (0.66, 3.66)
SCUD missile exploded within 1 mile 67 (48) 47 (31) 2.18 (1.27, 3.72)* 50 (52) 21 (28) 3.07 (1.53, 6.19)* 17 (40) 26 (33) 1.08 (0.46, 2.54)
Saw Iraqis/civilians badly wounded or killed 93 (65) 64 (40) 1.66 (0.92, 2.97) 85 (84) 54 (71) 1.55 (0.67, 3.58) 8 (19) 10 (12) 1.00 (0.30, 3.31)
Used pesticides on skin 80 (57) 49 (31) 1.65 (0.92, 2.95) 60 (61) 30 (40) 2.07 (1.06, 4.05)* 20 (47) 19 (23) 1.62 (0.63, 4.17)
Contact with prisoners of war 84 (59) 56 (35) 1.40 (0.77, 2.54) 74 (74) 44 (58) 1.70 (0.81, 3.58) 10 (23) 12 (14) 0.83 (0.24, 2.82)
Saw or came in contact with dead animals 75 (54) 54 (34) 1.37 (0.77, 2.43) 65 (66) 39 (52) 1.32 (0.65, 2.70) 10 (24) 15 (18) 0.87 (0.30, 2.49)
Contact with destroyed enemy vehicles 86 (60) 57 (36) 1.35 (0.75, 2.44) 80 (79) 52 (69) 1.39 (0.63, 3.05) 6 (14) 5 (6) 1.79 (0.44, 7.37)
Smoke from oil well fires 117 (82) 103 (65) 1.33 (0.69, 2.55) 92 (91) 63 (83) 2.78 (1.01, 7.66)* 25 (60) 40 (49) 1.36 (0.60, 3.09)
Received ≥ 1 shot in arm while in theater 99 (73) 88 (58) 1.31 (0.74, 2.32) 69 (73) 45 (59) 1.67 (0.81, 3.44) 30 (73) 43 (57) 1.52 (0.62, 3.72)
Was regular smoker during deployment 54 (38) 47 (29) 1.26 (0.72, 2.21) 41 (41) 27 (36) 0.96 (0.48, 1.93) 13 (32) 20 (24) 1.59 (0.65, 3.93)
Saw living area fogged/sprayed with pesticides 30 (22) 27 (17) 1.26 (0.63, 2.50) 26 (27) 13 (17) 1.26 (0.53, 3.00) 4 (10) 14 (17) 0.72 (0.22, 2.40)
Received ≥ 1 shot in buttocks while in theater 57 (43) 45 (29) 1.13 (0.64, 2.01) 43 (47) 27 (36) 1.30 (0.64, 2.63) 14 (34) 18 (23) 1.27 (0.50, 3.22)
Used/came into contact with freshly applied 
CARC paint
38 (29) 24 (17) 0.97 (0.48 -1.98) 36 (39) 21 (30) 0.88 (0.41, 1.88) 2 (5) 3 (4) 1.04 (0.14, 7.84)
Saw U.S. or allied troops badly wounded or killed 56 (39) 52 (33) 0.83 (0.46, 1.48) 46 (46) 33 (44) 0.69 (0.34, 1.40) 10 (23) 19 (23) 0.94 (0.35, 2.48)
Heard chemical alarms sounded 84 (59) 82 (53) 0.61 (0.34, 1.11) 61 (61) 44 (59) 0.78 (0.38, 1.58) 23 (55) 38 (47) 1.01 (0.44, 2.30)
Directly involved in ground combat 45 (32) 40 (25) 0.57 (0.29, 1.11) 45 (47) 40 (53) 0.47 (0.21, 1.02) — —
—, no observations. 
aAdjusted for being within 1 mile of exploding SCUD, wearing uniforms treated with pesticides, taking PB pills, and frequently having < 4 hr sleep in 24 hr. bAdjusted for being within 
1 mile of exploding SCUD missile, using pesticides on skin, and taking PB pills. cAdjusted for wearing uniforms treated with pesticides. *p < 0.05. Gulf War illness etiology I: wartime exposures
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to differences in patterns or degree of exposure 
by location. For example, personnel in forward 
areas, where nerve agent exposure was a prom‑
inent concern, likely used PB more frequently 
and for longer periods of time than did per‑
sonnel in support areas. Similarly, effects of oil 
smoke exposure would be expected to differ by 
location. Personnel nearer the burning oil well 
fires in Kuwait would have experienced, on 
average, greater and more sustained exposure 
to the dense smoke compared with personnel 
in areas farther away.
Personal‑use pesticides were significantly 
associated with GWI both for forward‑ 
deployed veterans in our sample and for those 
who remained in support areas. Widespread 
use of pesticides during the Gulf War has been 
credited with keeping rates of insect‑borne 
diseases much lower than in earlier military 
campaigns in the region (DOD 2003), but 
government reports also indicate that thou‑
sands of troops were over  exposed to pesticides 
during the 1990–1991 deployment. Among 
64 pesticide products used during the Gulf 
War, the 15 “pesticides of concern” identi‑
fied by the DOD (2003) include permethrin, 
a synthetic pyrethroid that impregnates fab‑
rics and persists through multiple launderings. 
Permethrin was recommended to be sprayed 
onto uniforms once every 6 weeks. Some pes‑
ticides of concern are no longer used by the 
military, including a 70% solution of the insect 
repellant DEET (N,N‑diethyl‑m‑toluamide) 
and lindane powder, an organochlorine used in 
delousing enemy prisoners of war and provided 
to some troops (predominantly Army person‑
nel) for personal use, intended for application 
to clothing (DOD 2003; Fricker et al. 2000).
According to detailed government inves‑
tigations of pesticide use during the Gulf 
War, U.S. military personnel were sometimes 
poorly informed about appropriate use of pes‑
ticides and repellants in theater (DOD 2003; 
Fricker et al. 2000). Pesticides were com‑
monly misused and over  used in an environ‑
ment rife with swarming and biting insects 
and with widespread concerns about diseases 
carried by sand flies and other pests (DOD 
2003; Fricker et al. 2000). For example, 
among individuals who used permethrin, the 
average frequency of use was about 30 appli‑
cations per month—far in excess of the rec‑
ommended use of once every 6 weeks. Animal 
and tissue studies have suggested that absorp‑
tion and chemical effects of permethrin can 
be modulated by PB, DEET, and other Gulf 
War–related exposures (Abou‑Donia et al. 
2004; Baynes et al. 2002). The association of 
GWI with use of pesticide‑treated uniforms 
in our study should therefore be considered in 
the context of several factors: a) use of pesti‑
cides on uniforms may not have been limited 
to permethrin, b) use of pesticides applied to 
uniforms was likely to have been excessively 
high in some individuals, and c) adverse 
effects of pesticides sprayed onto uniforms 
may have been enhanced by synergistic inter‑
actions with other pesticides and repellants.
Our study had several limitations. 
Evaluation of GWI case status relied on veteran‑ 
reported symptoms. Symptoms are, by def‑
inition, subjective in nature, but at present 
they are the only routine indicators of GWI 
morbidity. Our study also relied on veterans’ 
own reports of their wartime experiences for 
determining associations between GWI and 
exposures. This is problematic for a number of 
reasons, primarily related to errors introduced 
by inaccurate reporting or recall of exposures. 
Our finding that only a limited number of 
wartime exposures were significantly associ‑
ated with GWI allays to some degree concerns 
that recall bias was the likely explanation for 
apparent linkages between GWI and most 
self‑  reported exposures in several earlier stud‑
ies. The stark contrast between results obtained 
from assessing simple exposure–illness asso‑
ciations (not adjusted for effects of other expo‑
sures) and those obtained after multi  variable 
adjustments indicates that confounding was 
likely a much more pervasive problem than 
recognized in those studies.
Because of the many exposures of interest, 
epidemiologic studies of Gulf War veterans 
such as ours have generally reported results 
from multiple tests of association in a single 
population, raising the possibility that some 
significant findings occurred by chance. This 
cannot be ruled out entirely. However, our 
major findings regarding the prominence of PB 
and pesticides as risk factors for GWI are con‑
sistent with other Gulf War studies that used 
multi  variable analytic methods, suggesting that 
these associations did not randomly occur as a 
result of chance.
The size of our study population was suf‑
ficient only to detect significant risk factors 
associated with an OR ≥ 2 in the two veteran 
subgroups evaluated and did not allow us to 
evaluate more precisely defined subgroups. It 
is also possible that other exposures, not identi‑
fied by our data collection, occurred differen‑
tially by location in theater or within veteran 
subgroups and may account for differences in 
GWI prevalence. For example, we did not ask 
veterans if they had been exposed to chemical 
nerve agents because of limitations in their abil‑
ity to know the answer with any certainty. Two 
studies have reported brain structure alterations 
in Gulf War veterans potentially exposed to 
low‑level chemical nerve agents, as estimated 
by DOD models, in connection with weap‑
ons demolition opera  tions at Khamisiyah, Iraq 
(DOD 2002), after the Gulf War cease‑fire 
(Chao et al. 2010; Heaton et al. 2007).
In addition to our analytic approach, 
major strengths of our study include our sam‑
ple, selected randomly from among eligible 
veterans in a defined geographical area, pro‑
viding distinct advantages over clinical and 
registry‑based samples. We believe our use 
of the Kansas GWI case definition was also 
an important asset. We performed a series of 
exploratory analyses similar to those reported 
here but assigning case status based on the 
CDC MSI criteria (Fukuda et al. 1998). 
Results indicated that, although associations 
were consistently in the same direction as 
those reported here, they were considerably 
weaker using CDC criteria compared with 
using the Kansas GWI criteria.
Conclusions
Improved understanding of the causes of GWI 
remains essential, 20 years after Desert Storm, 
to clarify the biological nature of this problem 
and prevent its occurrence in future wars. Our 
results implicate Gulf War exposures, most 
prominently the use of pesticides and PB pills, 
as significant risk factors for GWI. More gen‑
erally, our findings suggest that the etiology 
of GWI is complex and likely involves several 
deployment‑related exposures whose relative 
contributions to the GWI problem differ in 
identifiable veteran subgroups.
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